| abstract |
The invention provides compounds of the general formula (I), where one of X and X is N, the other of X and X is -C (CH), A is unsubstituted or substituted 5-, 6-or 10-membered aryl or heteroaryl, n is 0 or 1 and B is a bicyclic heterofragment, such as defined in the description. The proposed compounds are inhibitors of phosphodiesterase 10A and can be used in medicine for the treatment of diseases or disorders of mental, neurological or cognitive functions. |